Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

44.09
+0.21500.49%
Volume:8.39M
Turnover:371.23M
Market Cap:63.89B
PE:17.86
High:44.67
Open:43.85
Low:43.65
Close:43.87
52wk High:105.65
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.45
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.56
PE(LYR):22.72

Loading ...

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 04

Boston Scientific Director Edward J. Ludwig Buys 5,000 Shares for $227,399.50

Reuters
·
Aug 04

Movement Alert|Boston Scientific Rises 3.72% in Regular Trading, Trading at $48.685

Market Focus
·
Aug 03

Boston Scientific FY26 Q2 Net Income Rises 13.8% to 907 Million; Net Sales Climb 7.5% to 5.44 Billion

Reuters
·
Aug 03

Why Boston Scientific (BSX) Is Up 5.6% After Mixed Q2, Recall News And Guidance Update

Simply Wall St.
·
Aug 02

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 01

Movement Alert|Boston Scientific Falls 3.13% in Regular Trading, Argus Downgrades Rating to Hold Extending Post-Earnings Selling Pressure

Market Focus
·
Jul 31

Argus Downgrades Boston Scientific to Hold From Buy

MT Newswires Live
·
Jul 31

Boston Scientific Cut to Hold from Buy by Argus Research

Dow Jones
·
Jul 31

Boston Scientific Corp : Argus Research Cuts to Hold from Buy

THOMSON REUTERS
·
Jul 31

Boston Scientific (BSX) Stock Ignores Margin Strength As Growth Outlook Softens

Simply Wall St.
·
Jul 31

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Penumbra Q2 FY26 Net Income Falls to 34.81 Million; Revenue Rises 14.9% to 390 Million

Reuters
·
Jul 31

Penumbra Q2 Revenue Slightly Beats Estimates, Helped by Product Segment Increase

Reuters
·
Jul 31

Cerus Q2 Adjusted Ebitda Misses Estimates, Raises 2026 Outlook

Reuters
·
Jul 31

Penumbra - Will not Provide Full Year 2026 Guidance or Host Conference Call Due to Pending Acquisition

THOMSON REUTERS
·
Jul 31

Boston Scientific's Watchman Slowdown Raises Utilization Questions, Oppenheimer Says

MT Newswires Live
·
Jul 31

Boston Scientific Lowered Full-Year Guidance on Headwinds in Electrophysiology, Watchman Portfolios, RBC Says

MT Newswires Live
·
Jul 30

Movement Alert|Boston Scientific Falls 3.06% in Regular Trading, Multiple Banks Cut Price Targets Post-Earnings on Watchman Weakness

Market Focus
·
Jul 30

UBS Adjusts Boston Scientific Price Target to $67 From $74, Maintains Buy Rating

MT Newswires Live
·
Jul 30